CHASITY STOVALL: Open Payments
NPI 1073016556 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 47 payments from 16 companies in 2025. Trend: 2023 $295 · 2024 $294 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $269 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Corcept Therapeutics | 2 | $57 |
| Amgen Inc. | 3 | $54 |
| ABBVIE INC. | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
Products named: Auvelity, CAPLYTA, XIFAXAN, Korlym, AIRSUPRA, BREZTRI, VRAYLAR, GEMTESA.
Industry payments across TX — which companies pay providers there.
